| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| ICICI Pru Nifty Pharma Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.62 |
| Equity |
99.97 |
| Trep |
0.65 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
56.99% |
| Top 10 Holdings |
79.73% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
99.97 |
| Cash |
0.03 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.01 |
| PE Ratio |
36.13 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
22.53 |
| DIVI LABORATORIES LTD |
9.72 |
| Dr Reddys Laboratories Limited |
9.49 |
| Cipla Limited |
8.67 |
| Lupin Limited |
6.58 |
| Torrent Pharmaceuticals Limited |
5.15 |
| Laurus Labs Limited |
5.04 |
| Aurobindo Pharma Limited |
4.57 |
| Glenmark Pharmaceuticals Limited |
4.26 |
| Alkem Laboratories Limited |
3.72 |
| Biocon Limited |
3.02 |
| Mankind Pharma Limited |
2.99 |
| Zydus Lifesciences Limited |
2.63 |
| IPCA Laboratories Limited |
2.50 |
| J B Chemicals and Pharma Ltd |
1.97 |
| Gland Pharma Limited |
1.64 |
| Abbott India Limited |
1.55 |
| Ajanta Pharma Limited |
1.40 |
| Wockhardt Limited |
1.36 |
| Piramal Pharma Limited |
1.18 |
| TREPS |
0.65 |
| Net Current Assets |
-0.62 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|